106 results
Industry
Industry
PROJECT NUMBER • 2018-097
PROJECT STATUS:
COMPLETED

Survey of Enterprise-level Biosecurity across the Australian Aquaculture Industry

The Australian Government Department of Agriculture and Water Resources (the department) commissioned the independent research company Instinct and Reason to conduct a survey aimed at farm owners/managers in the Australian aquaculture industry. The survey aimed to investigate the level of...
ORGANISATION:
Instinct and Reason
Industry
PROJECT NUMBER • 2021-061
PROJECT STATUS:
COMPLETED

Development of a guideline to investigate and understand disease outbreaks of unknown cause

This handbook presents guidelines that have been developed to use in the event of a disease outbreak in aquatic animals including finfish, molluscs and crustaceans. For the purposes of these guidelines, in the context of an outbreak, the term “disease” will be used for any event where...
ORGANISATION:
Agriculture Victoria
Industry
PROJECT NUMBER • 2019-106
PROJECT STATUS:
COMPLETED

Minor use permit for oxytetracycline in non-salmonid finfish

There are no registered or permitted antimicrobial products approved by the Australian Pesticide and Veterinary Medicine Authority (APVMA) for treatment of bacterial infections in finfish. This project developed an application for a minor-use permit (MUP) for the use of oxytetracycline (OTC) to...
ORGANISATION:
University of Adelaide
SPECIES
People
Industry
PROJECT NUMBER • 2018-090
PROJECT STATUS:
COMPLETED

Improving early detection surveillance and emergency disease response to Pacific Oyster Mortality Syndrome (POMS) using a hydrodynamic model for dispersion of OsHV-1

Rapid predictive capability of viral spread through water during an aquatic disease outbreak is an epidemiologist’s dream, and up until now has not been achievable. A biophysical particle tracking model for Ostreid herpesvirus 1 microvariant (OsHV-1) that causes POMS was developed to determine...
ORGANISATION:
Department of Primary Industries and Regions South Australia (PIRSA)
Industry
PROJECT NUMBER • 2019-086
PROJECT STATUS:
COMPLETED

Development of a national sector-specific biosecurity plan guideline and template for the farmed freshwater native finfish industry of Australia

These guidelines were developed as part of Fisheries Research and Development Corporation (FRDC) project number 2019-086: Development of a national sector-specific biosecurity plan guideline and template for the farmed freshwater native finfish industry of Australia and in accordance with: •...
ORGANISATION:
Freshwater Native Fish Association (FNFA)
TAGS

Minor use permit for erythromycin in finfish

Project number: 2021-027
Project Status:
Current
Budget expenditure: $95,000.00
Principal Investigator: Marty R. Deveney
Organisation: University of Adelaide
Project start/end date: 21 Oct 2021 - 30 Jul 2022
:

Need

There are no antimicrobials permitted or registered for use in finfish in Australia effective against gram positive bacteria (e.g. Streptococcus and Lactococcus). In finfish aquaculture, erythromycin (ERYC) is the best antimicrobial against gram positive organisms. The aquaculture industry and the Subcommittee for Aquatic Animal Health identified access to this product for finfinfish as a priority. Bacterial diseases are increasingly managed by eradication, maintenance of animals of specified health status, vaccination, and good hygiene, but antimicrobial therapy remains vital for treating bacterial diseases in finfish aquaculture. Appropriate use of antimicrobials can alleviate illness and suffering, improve welfare, increase speed of recovery, reduce spread of infection. Use of ERYC is not intended for prophylactic treatment, but as a tool for veterinarians to manage disease outbreaks. Use in South Australia, for example, is sporadic (~1 to 2 times per 3-5 years for a sector). The Aquaculture industry is committed to Australia's antimicrobial strategy, and as required by APVMA this proposal includes an antimicrobial resistance risk assessment. Available data for ERYC can satisfy the APVMA module requirements for efficacy, chemistry and manufacture, toxicology, trade and occupational health and safety. These are available in published literature, a range of industry studies of animals treated off-label and laboratory studies. There is a lack of data to satisfy the requirements mainly in the environment modules and the antimicrobial resistance risk assessment.

ERYC was ranked low by the Expert Advisory Group on Antimicrobial Assessment (EAGAR) as an antimicrobial for which there are a reasonable number of alternative agents in different classes available to treat most infections. Although it is listed on the WHO list of essential medicines, it is registered for use in cattle, pigs and sheep (APVMA #84160) and poultry (APVMA #50742) in Australia and the WHO list can be modified locally to suit the availability and sophistication of the animal and human health systems in WHO member countries. The APVMA PAA assessed ERYC as suitable for assessment for use in finfish.

Objectives

1. Obtain data to satisfy identified gaps and collate available data to satisfy requirements of minor use permit application.
2. Collate and submit minor use permit application.
Industry
PROJECT NUMBER • 2017-169
PROJECT STATUS:
COMPLETED

Assessing the nutritional value of Australian Barramundi

Farmed Australian barramundi (Lates calcarifer) is a reasonably well-recognised fish product in the Australian marketplace, however, its nutritional value and health benefits compared to other animal protein and seafoods is not quantified and widely known by consumers. This study assessed the...
ORGANISATION:
James Cook University (JCU)
SPECIES
Industry
View Filter

Organisation